Carbon footprints by stage of chronic kidney disease: The case of Japan

被引:0
|
作者
Nagai, Kei [1 ,2 ]
Hata, Sho [3 ]
Itsubo, Norihiro [4 ]
Iseki, Kunitoshi [5 ]
Yamagata, Kunihiro [2 ]
Nansai, Keisuke [3 ]
机构
[1] Hitachi Gen Hosp, Dept Nephrol, 2-1-1 Jonan Cho, Hitachi, Ibaraki 3170077, Japan
[2] Univ Tsukuba, Fac Med, Dept Nephrol, 1-1-1 Ten Nodai, Tsukuba, Ibaraki 3058575, Japan
[3] Natl Inst Environm Studies, Mat Cycles Div, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan
[4] Tokyo City Univ, Fac Environm & Informat Studies, 3-3-1 Ushikubo Nishi,Tsuzuki Ku, Yokohama, Kanagawa 2248551, Japan
[5] Nakamura Clin, Clin Res Support Ctr, 4-2-1 Iso, Urasoe, Okinawa 9012132, Japan
来源
关键词
Chronic kidney disease; Carbon footprint; Dialysis therapy; GLOMERULAR-FILTRATION-RATE; RISK-FACTOR;
D O I
10.1016/j.joclim.2023.100294
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Introduction: The nexus between carbon footprints and chronic kidney disease (CKD) progression have not been clarified, so it has not been possible to examine the prevention of disease severity as a potential countermeasure for decarbonization. Material and methods: The study included 70,627 subjects aged 40 -74 years and diagnosed with CKD stage by specific health checkups in 2014 -2015. Greenhouse gas (GHG) emissions in Japan were formulated with the 2015 environmental input -output model. The carbon footprints by CKD stage were calculated with annual treatment cost according to renal function indicators, namely estimated glomerular filtration rate (eGFR) and proteinuria. Results: The annual carbon footprint per patient with induction of dialysis due to CKD was estimated to be 3.9 tCO 2 e, in contrast to 0.31 tCO 2 e in subjects without dialysis. Highlighting the relationship between the carbon footprint and the slope of eGFR as the CKD stage advances, the carbon footprint of care for patients with a stable eGFR in CKD stage G2 or better was 300 kgCO 2 e in males and 280 kgCO 2 e in females. Yet, in CKD stages G3a and G3b or worse, the carbon footprint for a rapid decrease in eGFR (30 % or greater per year) was 620 kgCO 2 e and 1440 kgCO 2 e in males and 430 kgCO 2 e and 1270 kgCO 2 e in females, respectively. Conclusion: Effective interventional treatments to prevent disease severity in CKD contribute to both the health of the patient and the mitigation of GHG emissions. (c) 2023 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Screening of Fabry disease in patients with chronic kidney disease in Japan
    Nagata, Akiko
    Nasu, Makoto
    Kaida, Yusuke
    Nakayama, Yosuke
    Kurokawa, Yuka
    Nakamura, Nao
    Shibata, Ryo
    Hazama, Takuma
    Tsukimura, Takahiro
    Togawa, Tadayasu
    Saito, Seiji
    Sakuraba, Hitoshi
    Fukami, Kei
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (01) : 115 - 125
  • [22] CLINICAL PREDICTION MODELS FOR PROGRESSION OF CHRONIC KIDNEY DISEASE TO END STAGE KIDNEY FAILURE UNDER PREDIALYSIS NEPHROLOGY CARE: RESULTS FROM THE CHRONIC KIDNEY DISEASE JAPAN COHORT STUDY
    Hasegawa, Takeshi
    Sakamaki, Kentaro
    Koiwa, Fumihiko
    Akizawa, Tadao
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1439 - 1439
  • [23] Children with Chronic Kidney Disease and Hypertension: Could Hypertension Footprints be Early Biomarkers?
    Balat, Ayse
    [J]. CURRENT HYPERTENSION REVIEWS, 2014, 10 (02) : 86 - 98
  • [24] Machine learning to predict end stage kidney disease in chronic kidney disease
    Bai, Qiong
    Su, Chunyan
    Tang, Wen
    Li, Yike
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [25] Machine learning to predict end stage kidney disease in chronic kidney disease
    Qiong Bai
    Chunyan Su
    Wen Tang
    Yike Li
    [J]. Scientific Reports, 12
  • [26] CHRONIC KIDNEY DISEASE, END STAGE RENAL DISEASE, AND KIDNEY TRANSPLANTATION IN SURINAME
    Panday, V. Nannan
    Diemer, F. S.
    Haan, Y. C.
    Punwasi, A.
    Rommy, C.
    Van Montfrans, G. A.
    Oehlers, G. P.
    Brewster, L. M.
    [J]. JOURNAL OF HYPERTENSION, 2017, 35 : E142 - E142
  • [27] Metabolic syndrome and chronic kidney disease in Okinawa, Japan
    Tanaka, H
    Shiohira, Y
    Uezu, Y
    Higa, A
    Iseki, K
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (02) : 369 - 374
  • [28] Nephrologists sans frontieres: Chronic kidney disease in japan
    Sasaki, S
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (09) : 1485 - 1486
  • [29] Predicted prevalence in Japan of chronic kidney disease (CKD)
    Genjiro Kimura
    [J]. Clinical and Experimental Nephrology, 2007, 11 (2) : 188 - 189